Wird geladen...
Model-based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: Methods and challenges
Novel therapies are challenging the standards of drug development. Agents with specific biologic targets, unknown dose-efficacy curves, and limited toxicity mandate novel designs to identify biologically optimal doses. We review two model-based designs that utilize either a proportional odds model o...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2010
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931331/ https://ncbi.nlm.nih.gov/pubmed/20419760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.3706 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|